There were 3 companies that had their AIM quotations cancelled in March, while Summerway Capital was readmitted as Celadon Pharmaceuticals (LON: CEL) on 28 March following the reverse takeover of Vertigrow Technology, which grows indoor hydroponic, high THC cannabis, which will be used for medicines to treat chronic pain.
Two companies were taken over and the other decided it wanted to leave AIM, although it has arranged an alternative matched bargains trading facility.
=====
7 March 2...
You are unauthorized to view this page.